FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3061646 · Received April 16, 2013

Report

Report Number
1030489-2013-01063
Event Type
Injury
Date Received
April 16, 2013
Report Date
December 15, 2017
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(6). (B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT SUSTAINED UNSPECIFIED INJURIES FOLLOWING THE USE OF RHBMP-2/ACS IN AN UNSPECIFIED SPINAL FUSION SURGERY. NO ADDITIONAL INFORMATION WAS REPORTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2007, PATIENT WAS ADMITTED TO THE FACILITY WHERE THE SURGEON PERFORMED SPINE FUSION SURGERY USING RHBMP2 ON THE LUMBAR REGION OF HIS SPINE FROM VERTEBRAE L4 TO S1. THE RHBMP-2 COLLAGEN SPONGE WAS USED TO FUSE MORE THAN ONE LEVEL OF THE SPINE. THE RHBMP-2 COLLAGEN SPONGE WAS PLACED OUTSIDE A CAGE (I.E., IN THE DISC SPACE, POSTEROLATERAL GUTTERS, AND OVER POSTERIOR ELEMENTS). POST-OP, PATIENT REPORTEDLY HAD LOW BACK AND LEG PAIN GREW IN SEVERITY UNTIL HE REQUIRED A REVISION SURGERY ON (B)(6) 2007.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
162165 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA M110605AAD

Patients

Seq Age Sex Outcome Treatment
1 Other| R